Phase 2 trial for hematological CR patients of AML after chemotherapy.
Not Applicable
- Conditions
- Acute myeloid leukemia
- Registration Number
- JPRN-UMIN000015870
- Lead Sponsor
- Osaka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
AML associated with MPD double cancer active infection post hematological stem cell transplantation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method